Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Change in Receivables: 2017-2024

Historic Change in Receivables for Assembly Biosciences (ASMB) over the last 8 years, with Dec 2024 value amounting to -$43,000.

  • Assembly Biosciences' Change in Receivables was N/A to $912,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $570,000, marking a year-over-year change of. This contributed to the annual value of -$43,000 for FY2024, which is 95.23% up from last year.
  • Assembly Biosciences' Change in Receivables amounted to -$43,000 in FY2024, which was up 95.23% from -$901,000 recorded in FY2023.
  • Assembly Biosciences' Change in Receivables' 5-year high stood at $608,000 during FY2022, with a 5-year trough of -$2.1 million in FY2020.
  • In the last 3 years, Assembly Biosciences' Change in Receivables had a median value of -$43,000 in 2024 and averaged -$112,000.
  • In the last 5 years, Assembly Biosciences' Change in Receivables slumped by 327.12% in 2020 and then surged by 168.01% in 2022.
  • Over the past 5 years, Assembly Biosciences' Change in Receivables (Yearly) stood at -$2.1 million in 2020, then surged by 58.30% to -$894,000 in 2021, then soared by 168.01% to $608,000 in 2022, then plummeted by 248.19% to -$901,000 in 2023, then spiked by 95.23% to -$43,000 in 2024.